Priority 29 from the Contraception PSP
| UNCERTAINTY: What risk factors are there for deep insertion of implants? (JLA PSP Priority 29) | |
|---|---|
| Overall ranking | 29 |
| JLA question ID | 0049/29 |
| Explanatory note | The use of LARCs is increasing, the most commonly used LARC in England is the implant (12.9% attendees at community SRH clinics, 159 thousand prescriptions. It is important that rare complications are monitored by the NHS rather than just the manufacturer. “ a woman's choice and acceptance of LARC may be influenced by potential health dis-benefits (side effects and risks) as well as non contraceptive benefits of LARC)” The short and long term effects of contraceptive choices were a frequently raised by patients and healthcare professionals. There is some overlap with this and priority 2. |
| Evidence |
Progestogen-only Implants; CEU Statement: Intravascular insertion of Nexplanon® - June 2016 |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples |
Are deep implant insertions more common if the insertion was done as part of a removal and refit procedure? (both) |
| Submitted by | Healthcare Professionals x 0~Patients x 0~Both x 1 |
| PSP information | |
|---|---|
| PSP unique ID | 0049 |
| PSP name | Contraception |
| Total number of uncertainties identified by this PSP. | 57 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 21 April 2017 |